Frontiers in pharmaceutical nanotechnology
Department of Pharmacy
Faculty of Science
National University of Singapore
Today, a wide spectrum of nanomedicines is being developed for the diagnosis, prevention and treatment of disease. Recent breakthroughs include the delivery of small molecules, therapeutic proteins or peptides, and great progress has been made in the material design and targeting of nanocarriers to specific tissues or across biological barriers. However, converting the strategies into products is still challenging, and many nanomedicines fail to comply with the market requirements or during the clinical trials. This thematic issue presents recent research in the design, manufacture and testing of nanomedicines.
This thematic issue is dedicated to Prof. Dr. Jörg Kreuter, a pioneer of this whole research area, whose contributions have been widely recognized. With more than 300 publications, he has shaped pharmaceutical nanotechnology for the last 40 years.
Download all of the articles in this thematic issue as one PDF by clicking on "Download Issue".
Frontiers in pharmaceutical nanotechnology
- Matthias G. Wacker
Beilstein J. Nanotechnol. 2019, 10, 2538–2540, doi:10.3762/bjnano.10.244
Tungsten disulfide-based nanocomposites for photothermal therapy
- Tzuriel Levin,
- Hagit Sade,
- Rina Ben-Shabbat Binyamini,
- Maayan Pour,
- Iftach Nachman and
- Jean-Paul Lellouche
Beilstein J. Nanotechnol. 2019, 10, 811–822, doi:10.3762/bjnano.10.81
Serum type and concentration both affect the protein-corona composition of PLGA nanoparticles
- Katrin Partikel,
- Robin Korte,
- Dennis Mulac,
- Hans-Ulrich Humpf and
- Klaus Langer
Beilstein J. Nanotechnol. 2019, 10, 1002–1015, doi:10.3762/bjnano.10.101
Nanoporous smartPearls for dermal application – Identification of optimal silica types and a scalable production process as prerequisites for marketed products
- David Hespeler,
- Sanaa El Nomeiri,
- Jonas Kaltenbach and
- Rainer H. Müller
Beilstein J. Nanotechnol. 2019, 10, 1666–1678, doi:10.3762/bjnano.10.162
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
- Hannah Onafuye,
- Sebastian Pieper,
- Dennis Mulac,
- Jindrich Cinatl Jr.,
- Mark N. Wass,
- Klaus Langer and
- Martin Michaelis
Beilstein J. Nanotechnol. 2019, 10, 1707–1715, doi:10.3762/bjnano.10.166
Lipid nanostructures for antioxidant delivery: a comparative preformulation study
- Elisabetta Esposito,
- Maddalena Sguizzato,
- Markus Drechsler,
- Paolo Mariani,
- Federica Carducci,
- Claudio Nastruzzi,
- Giuseppe Valacchi and
- Rita Cortesi
Beilstein J. Nanotechnol. 2019, 10, 1789–1801, doi:10.3762/bjnano.10.174
Preservation of rutin nanosuspensions without the use of preservatives
- Pascal L. Stahr and
- Cornelia M. Keck
Beilstein J. Nanotechnol. 2019, 10, 1902–1913, doi:10.3762/bjnano.10.185
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activity
- Sebastian Pieper,
- Hannah Onafuye,
- Dennis Mulac,
- Jindrich Cinatl Jr.,
- Mark N. Wass,
- Martin Michaelis and
- Klaus Langer
Beilstein J. Nanotechnol. 2019, 10, 2062–2072, doi:10.3762/bjnano.10.201
BergaCare SmartLipids: commercial lipophilic active concentrates for improved performance of dermal products
- Florence Olechowski,
- Rainer H. Müller and
- Sung Min Pyo
Beilstein J. Nanotechnol. 2019, 10, 2152–2162, doi:10.3762/bjnano.10.208
Microfluidics as tool to prepare size-tunable PLGA nanoparticles with high curcumin encapsulation for efficient mucus penetration
- Nashrawan Lababidi,
- Valentin Sigal,
- Aljoscha Koenneke,
- Konrad Schwarzkopf,
- Andreas Manz and
- Marc Schneider
Beilstein J. Nanotechnol. 2019, 10, 2280–2293, doi:10.3762/bjnano.10.220
Design of a nanostructured mucoadhesive system containing curcumin for buccal application: from physicochemical to biological aspects
- Sabrina Barbosa de Souza Ferreira,
- Gustavo Braga,
- Évelin Lemos Oliveira,
- Jéssica Bassi da Silva,
- Hélen Cássia Rosseto,
- Lidiane Vizioli de Castro Hoshino,
- Mauro Luciano Baesso,
- Wilker Caetano,
- Craig Murdoch,
- Helen Elizabeth Colley and
- Marcos Luciano Bruschi
Beilstein J. Nanotechnol. 2019, 10, 2304–2328, doi:10.3762/bjnano.10.222
Internalization mechanisms of cell-penetrating peptides
- Ivana Ruseska and
- Andreas Zimmer
Beilstein J. Nanotechnol. 2020, 11, 101–123, doi:10.3762/bjnano.11.10
Phase inversion-based nanoemulsions of medium chain triglyceride as potential drug delivery system for parenteral applications
- Eike Folker Busmann,
- Dailén García Martínez,
- Henrike Lucas and
- Karsten Mäder
Beilstein J. Nanotechnol. 2020, 11, 213–224, doi:10.3762/bjnano.11.16
Key for crossing the BBB with nanoparticles: the rational design
- Sonia M. Lombardo,
- Marc Schneider,
- Akif E. Türeli and
- Nazende Günday Türeli
Beilstein J. Nanotechnol. 2020, 11, 866–883, doi:10.3762/bjnano.11.72
